AU2174783A - 3-thiovinyl cephalosporin derivatives - Google Patents

3-thiovinyl cephalosporin derivatives

Info

Publication number
AU2174783A
AU2174783A AU21747/83A AU2174783A AU2174783A AU 2174783 A AU2174783 A AU 2174783A AU 21747/83 A AU21747/83 A AU 21747/83A AU 2174783 A AU2174783 A AU 2174783A AU 2174783 A AU2174783 A AU 2174783A
Authority
AU
Australia
Prior art keywords
isomer
nujol
cephem
carboxylate
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21747/83A
Other languages
English (en)
Inventor
Takashi Masugi
Takashi Ogino
Hisashi Takasugi
Takao Takaya
Hideaki Yamanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838300122A external-priority patent/GB8300122D0/en
Priority claimed from GB838317496A external-priority patent/GB8317496D0/en
Priority claimed from GB838329768A external-priority patent/GB8329768D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU2174783A publication Critical patent/AU2174783A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
AU21747/83A 1982-12-06 1983-11-28 3-thiovinyl cephalosporin derivatives Abandoned AU2174783A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8234755 1982-12-06
GB8234755 1982-12-06
GB838300122A GB8300122D0 (en) 1983-01-05 1983-01-05 Cephem compounds
GB8300122 1983-01-05
GB8317496 1983-06-28
GB838317496A GB8317496D0 (en) 1983-06-28 1983-06-28 Cephem compounds
GB838329768A GB8329768D0 (en) 1983-11-08 1983-11-08 Cephem compounds
GB8329768 1983-11-08

Publications (1)

Publication Number Publication Date
AU2174783A true AU2174783A (en) 1984-06-14

Family

ID=27449416

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21747/83A Abandoned AU2174783A (en) 1982-12-06 1983-11-28 3-thiovinyl cephalosporin derivatives

Country Status (17)

Country Link
US (2) US4584290A (enExample)
EP (1) EP0111281B1 (enExample)
JP (1) JPH0639475B2 (enExample)
KR (1) KR840007011A (enExample)
AU (1) AU2174783A (enExample)
CH (1) CH656882A5 (enExample)
DE (1) DE3381627D1 (enExample)
DK (1) DK554483A (enExample)
ES (3) ES8506729A1 (enExample)
FI (1) FI834413A7 (enExample)
FR (1) FR2537141B1 (enExample)
GB (1) GB2139617B (enExample)
GR (1) GR79043B (enExample)
IT (1) IT1168734B (enExample)
NO (1) NO834463L (enExample)
OA (1) OA07602A (enExample)
PT (1) PT77772B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79043B (enExample) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
WO1994006804A1 (fr) * 1992-09-18 1994-03-31 Otsuka Kagaku Kabushiki Kaisha Compose de cepheme, son procede de production et medicament le contenant
US5698544A (en) * 1994-03-17 1997-12-16 Otsuka Kagaku Kabushiki Kaisha Cephem compound, process for producing the compound, and antimicrobial composition containing the same
AU4496896A (en) * 1995-01-30 1996-08-21 Takeda Chemical Industries Ltd. Cephem compounds, their production and use
AU5781396A (en) * 1995-05-29 1996-12-18 Takeda Chemical Industries Ltd. Cephem compounds, their production and use
AU707822B2 (en) * 1995-07-13 1999-07-22 Koninklijke Philips Electronics N.V. Method and system for data repetition between logically successive clusters
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
US6025352A (en) * 1997-09-29 2000-02-15 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
AUPO973297A0 (en) * 1997-10-10 1997-11-06 Fujisawa Pharmaceutical Co., Ltd. New compound
EP1478649A4 (en) * 2002-02-28 2006-09-13 Lg Life Sciences Ltd NOVEL CEPHALOSPORINE-BASED COMPOUNDS AND METHOD OF MANUFACTURING THE SAME
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN104177408B (zh) * 2014-09-12 2016-09-07 衡水衡林生物科技有限公司 (z)-2-(5-二氯磷酰氨基-1,2,4-噻二唑-3-基)-2-乙氧亚胺基乙酰氯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193798A (en) * 1979-05-23 1983-11-18 Rhone Poulenc Ind 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
FR2494280A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
GR79043B (enExample) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
DE3381627D1 (de) 1990-07-12
PT77772A (en) 1984-01-01
DK554483A (da) 1984-06-07
IT1168734B (it) 1987-05-20
IT8324035A0 (it) 1983-12-05
US4584290A (en) 1986-04-22
EP0111281B1 (en) 1990-06-06
ES8505690A1 (es) 1985-06-01
EP0111281A2 (en) 1984-06-20
ES527790A0 (es) 1985-07-16
GB8331713D0 (en) 1984-01-04
US4719206A (en) 1988-01-12
GR79043B (enExample) 1984-10-02
ES534203A0 (es) 1985-07-16
FI834413A7 (fi) 1984-06-07
ES8506729A1 (es) 1985-07-16
CH656882A5 (de) 1986-07-31
KR840007011A (ko) 1984-12-04
FR2537141B1 (fr) 1987-02-27
FI834413A0 (fi) 1983-12-02
OA07602A (fr) 1985-03-31
JPH0639475B2 (ja) 1994-05-25
GB2139617B (en) 1986-09-24
NO834463L (no) 1984-06-07
GB2139617A (en) 1984-11-14
EP0111281A3 (en) 1985-07-03
JPS59130292A (ja) 1984-07-26
PT77772B (en) 1986-04-17
ES534202A0 (es) 1985-06-01
FR2537141A1 (fr) 1984-06-08
ES8506730A1 (es) 1985-07-16
DK554483D0 (da) 1983-12-01

Similar Documents

Publication Publication Date Title
AU547984B2 (en) Cephalosporin derivatives
AU585831B2 (en) Cephalosporin derivatives
GB2117770B (en) Cephalosporin derivatives
AU3388384A (en) Cephalosporin derivatives
AU7517181A (en) Cephalosporin derivatives
AU562776B2 (en) Cephalosporin derivatives
DE3368638D1 (en) Cephalosporin derivatives
AU1631083A (en) Trans-delta2-prostoglandin d derivatives
AU561960B2 (en) Indolylglycyl cephalosporin derivatives
AU558586B2 (en) Cephalosporin derivatives
AU546730B2 (en) Cephalosporin derivatives
AU2673684A (en) Benzothienylglycyl cephalosporin derivatives
AU536771B2 (en) Cephalosporin derivatives
AU546117B2 (en) Cephalosporin derivatives
AU2161783A (en) Cephalosporin antibioties
AU2673584A (en) Benzothienylglycyl cephalosporin derivatives
EP0113242A3 (en) Cephalosporin derivatives
AU3384284A (en) Azolyl-tetrahydrofuran-2-ylidene-methane derivatives
AU2673884A (en) Naphthylglycyl cephalosporin derivatives
DE3379404D1 (en) Cephalosporin derivatives
AU7133381A (en) Cephalosporin derivatives
AU8166182A (en) Cephalosporin derivatives
AU8040182A (en) Cephalosporin derivatives
DE3379464D1 (en) Cephalosporin derivatives
AU7491481A (en) Cephalosporin derivatives